82 related articles for article (PubMed ID: 3136392)
21. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
22. Effects of cortisol and cocaine on plasma prolactin and growth hormone levels in cocaine-dependent volunteers.
Elman I; Lukas SE
Addict Behav; 2005 May; 30(4):859-64. PubMed ID: 15833589
[TBL] [Abstract][Full Text] [Related]
23. Serum prolactin levels during extended cocaine abstinence.
Swartz CM; Breen K; Leone F
Am J Psychiatry; 1990 Jun; 147(6):777-9. PubMed ID: 2343924
[TBL] [Abstract][Full Text] [Related]
24. Difficulties in emotion regulation and impulse control during cocaine abstinence.
Fox HC; Axelrod SR; Paliwal P; Sleeper J; Sinha R
Drug Alcohol Depend; 2007 Jul; 89(2-3):298-301. PubMed ID: 17276626
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis of hyperprolactinemia: determination of prolactin level at rest].
Ishay A; Luboshitzky R
Harefuah; 1998 Nov; 135(9):348-50, 408, 407. PubMed ID: 10911442
[TBL] [Abstract][Full Text] [Related]
26. Polycystic ovary syndrome and hyperprolactinemia are distinct entities.
Filho RB; Domingues L; Naves L; Ferraz E; Alves A; Casulari LA
Gynecol Endocrinol; 2007 May; 23(5):267-72. PubMed ID: 17558684
[TBL] [Abstract][Full Text] [Related]
27. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
28. Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
Hollander E; Nunes E; DeCaria CM; Quitkin FM; Cooper T; Wager S; Klein DF
Psychiatry Res; 1990 Aug; 33(2):161-9. PubMed ID: 2243893
[TBL] [Abstract][Full Text] [Related]
29. Bromocriptine in cocaine withdrawal--does it work?
Teller DW; Devenyi P
Int J Addict; 1988 Nov; 23(11):1197-205. PubMed ID: 3069753
[TBL] [Abstract][Full Text] [Related]
30. Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.
Walsh SL; Stoops WW; Moody DE; Lin SN; Bigelow GE
Exp Clin Psychopharmacol; 2009 Aug; 17(4):205-16. PubMed ID: 19653786
[TBL] [Abstract][Full Text] [Related]
31. Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis.
Hou SH; Grossman S; Molitch ME
Am J Kidney Dis; 1985 Oct; 6(4):245-9. PubMed ID: 4050782
[TBL] [Abstract][Full Text] [Related]
32. Serum prolactin and response to treatment among cocaine-dependent individuals.
Patkar AA; Hill KP; Sterling RC; Gottheil E; Berrettini WH; Weinstein SP
Addict Biol; 2002 Jan; 7(1):45-53. PubMed ID: 11900622
[TBL] [Abstract][Full Text] [Related]
33. Plasma prolactin levels and cocaine abuse.
Mendelson JH
Am J Psychiatry; 1991 Mar; 148(3):397. PubMed ID: 1992852
[No Abstract] [Full Text] [Related]
34. Hyperprolactinemia and risk for relapse of cocaine abuse.
Teoh SK; Mendelson JH; Mello NK; Weiss R; McElroy S; McAfee B
Biol Psychiatry; 1990 Nov; 28(9):824-8. PubMed ID: 2257288
[No Abstract] [Full Text] [Related]
35. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic renal insufficiency.
Caticha O; Norato DY; Tambascia MA; Santana A; Stephanou A; Sarlis NJ
J Endocrinol Invest; 1996; 19(7):441-8. PubMed ID: 8884538
[TBL] [Abstract][Full Text] [Related]
36. [Prolactin in the blood serum of patients with multiple sclerosis].
Nowak S; Kowalski D; Kowalska K; Błaszczyk B
Neurol Neurochir Pol; 1987; 21(3):202-6. PubMed ID: 3670526
[TBL] [Abstract][Full Text] [Related]
37. Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence.
Patkar AA; Mannelli P; Certa KM; Peindl K; Murray H; Vergare MJ; Berrettini WH
Psychopharmacology (Berl); 2004 Oct; 176(1):74-81. PubMed ID: 15064918
[TBL] [Abstract][Full Text] [Related]
38. Hyperprolactinemia diagnostics--dilemmas over optimal selection of prolactinemia time points.
Szosland K; Stasiak M; Lewiński A
Ann Agric Environ Med; 2015; 22(2):332-7. PubMed ID: 26094534
[TBL] [Abstract][Full Text] [Related]
39. Stimulant withdrawal.
Lago JA; Kosten TR
Addiction; 1994 Nov; 89(11):1477-81. PubMed ID: 7841859
[TBL] [Abstract][Full Text] [Related]
40. The utility of prolactin serial sampling and the best prolactin cut-offs associated with persistent hyperprolactinemia.
Cidade-Rodrigues C; Cunha FM; Chaves C; Silva-Vieira M; Silva A; Garrido S; Martinho M; Almeida M
Porto Biomed J; 2021; 6(2):e133. PubMed ID: 33869885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
